Back

Enhanced cholera surveillance as a tool for improving vaccination campaign efficiency

Xu, H.; Zou, K.; Wiens, K. E.; Bwenge, E. M.; Azman, A. S.; Lee, E. C.

2022-11-27 epidemiology
10.1101/2022.11.25.22282776 medRxiv
Show abstract

Systematic testing for Vibrio cholerae O1 is rare, which means that the worlds limited supply of oral cholera vaccines may not be delivered to areas with the highest true cholera burden. We modeled how expanding V. cholerae testing affected vaccine impact and cost-effectiveness across different bacteriological confirmation and vaccine targeting assumptions. Systematic testing yielded higher efficiency and cost-effectiveness and slightly fewer averted cases than status quo scenarios targeting suspected cholera. With a 10 per 10,000 incidence rate targeting threshold, testing and status quo scenarios averted 10.3 (95% PI: 8.3-13.0) and 5.6 (95% PI: 4.6-6.7) cases per 1,000 FVPs, respectively. Comparing these scenarios, testing costs increased by $37 (95% PI: 29-52) while vaccination costs reduced by $376 (95% PI: 275-556) per averted case. Introduction of systematic testing into cholera surveillance could improve efficiency and reach of global OCV supply for preventive vaccination.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.